New Key Statistics Module, Z-Score and F-Score
OTCPK:INBP Key Ratios
Market Cap $ M | 9.63 |
Enterprise Value $ M | 8.85 |
P/E(ttm) | 26.67 |
PE Ratio without NRI | 26.67 |
Forward PE Ratio | -- |
Price/Book | 0.50 |
Price/Sales | 0.20 |
Price/Free Cash Flow | 21.34 |
Price/Owner Earnings | 24.61 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 50.00 |
EPS (TTM) $ | 0.01 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -2.10 |
5-y EBITDA Growth Rate % | -22.10 |
y-y EBITDA Growth Rate % | 11.60 |
EV-to-EBIT | 35.26 |
EV-to-EBITDA | 5.00 |
PEG | -- |
Shares Outstanding M | 30.10 |
Net Margin (%) | 0.22 |
Operating Margin % | 0.50 |
Pre-tax Margin (%) | 0.53 |
Quick Ratio | 1.08 |
Current Ratio | 2.92 |
ROA % (ttm) | 0.43 |
ROE % (ttm) | 0.59 |
ROIC % (ttm) | 0.54 |
Dividend Yield % | -- |
Altman Z-Score | 1.69 |
INBP Number of Guru Trades
INBP Volume of Guru Trades
Gurus Latest Trades with OTCPK:INBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:INBP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Integrated Biopharma Inc Insider Transactions
No Available Data
News about OTCPK:INBP
Total 0- 1